A citation-based method for searching scientific literature

Morgan L Maeder, Michael Stefanidakis, Christopher J Wilson, Reshica Baral, Luis Alberto Barrera, George S Bounoutas, David Bumcrot, Hoson Chao, Dawn M Ciulla, Jennifer A DaSilva, Abhishek Dass, Vidya Dhanapal, Tim J Fennell, Ari E Friedland, Georgia Giannoukos, Sebastian W Gloskowski, Alexandra Glucksmann, Gregory M Gotta, Hariharan Jayaram, Scott J Haskett, Bei Hopkins, Joy E Horng, Shivangi Joshi, Eugenio Marco, Rina Mepani, Deepak Reyon, Terence Ta, Diana G Tabbaa, Steven J Samuelsson, Shen Shen, Maxwell N Skor, Pam Stetkiewicz, Tongyao Wang, Clifford Yudkoff, Vic E Myer, Charles F Albright, Haiyan Jiang. Nat Med 2019
Times Cited: 267



You Lu, Jianxin Xue, Tao Deng, Xiaojuan Zhou, Kun Yu, Lei Deng, Meijuan Huang, Xin Yi, Maozhi Liang, Yu Wang, Haige Shen, Ruizhan Tong, Wenbo Wang, Li Li, Jin Song, Jing Li, Xiaoxing Su, Zhenyu Ding, Youling Gong, Jiang Zhu, Yongsheng Wang, Bingwen Zou, Yan Zhang, Yanying Li, Lin Zhou, Yongmei Liu, Min Yu, Yuqi Wang, Xuanwei Zhang, Limei Yin, Xuefeng Xia, Yong Zeng, Qiao Zhou, Binwu Ying, Chong Chen, Yuquan Wei, Weimin Li, Tony Mok. Nat Med 2020
Times Cited: 153




List of shared articles



Times cited

New approaches to moderate CRISPR-Cas9 activity: Addressing issues of cellular uptake and endosomal escape.
Maja van Hees, Sofie Slott, Anders Højgaard Hansen, Heon Seok Kim, Hanlee P Ji, Kira Astakhova. Mol Ther 2022
3

CRISPR-based therapeutics: current challenges and future applications.
Ashley E Modell, Donghyun Lim, Tuan M Nguyen, Vedagopuram Sreekanth, Amit Choudhary. Trends Pharmacol Sci 2022
4

CRISPR-based genome editing through the lens of DNA repair.
Tarun S Nambiar, Lou Baudrier, Pierre Billon, Alberto Ciccia. Mol Cell 2022
9

Basic Principles and Clinical Applications of CRISPR-Based Genome Editing.
Jung Min Lim, Hyongbum Henry Kim. Yonsei Med J 2022
2

Reverting TP53 Mutation in Breast Cancer Cells: Prime Editing Workflow and Technical Considerations.
Asmaa Y Abuhamad, Nurul Nadia Mohamad Zamberi, Ling Sheen, Safaa M Naes, Siti Nur Hasanah Mohd Yusuf, Asilah Ahmad Tajudin, M Aiman Mohtar, Amir Syahir Amir Hamzah, Saiful Effendi Syafruddin. Cells 2022
0

The origin of unwanted editing byproducts in gene editing.
Jianhang Yin, Jiazhi Hu. Acta Biochim Biophys Sin (Shanghai) 2022
1

Message in hand: the application of CRISPRi, RNAi, and LncRNA in adenocarcinoma.
Ting Wang, Yunhong Yao, Xinrong Hu, Yi Zhao. Med Oncol 2022
0

A Novel Anti-Cancer Therapy: CRISPR/Cas9 Gene Editing.
Xin-Zhu Chen, Rong Guo, Cong Zhao, Jing Xu, Hang Song, Hua Yu, Christian Pilarsky, Firzan Nainu, Jing-Quan Li, Xin-Ke Zhou,[...]. Front Pharmacol 2022
0

Cas9-directed immune tolerance in humans-a model to evaluate regulatory T cells in gene therapy?
Dimitrios Laurin Wagner, Lena Peter, Michael Schmueck-Henneresse. Gene Ther 2021
11

Evaluation of CRISPR/Cas9 site-specific function and validation of sgRNA sequence by a Cas9/sgRNA-assisted reverse PCR technique.
Beibei Zhang, Jiamu Zhou, Miao Li, Yuanmeng Wei, Jiaojiao Wang, Yange Wang, Pingling Shi, Xiaoli Li, Zixu Huang, He Tang,[...]. Anal Bioanal Chem 2021
0

Genome-editing approaches and applications: a brief review on CRISPR technology and its role in cancer.
Narmadhaa Siva, Sonal Gupta, Ayam Gupta, Jayendra Nath Shukla, Babita Malik, Nidhi Shukla. 3 Biotech 2021
4

Chromothripsis as an on-target consequence of CRISPR-Cas9 genome editing.
Mitchell L Leibowitz, Stamatis Papathanasiou, Phillip A Doerfler, Logan J Blaine, Lili Sun, Yu Yao, Cheng-Zhong Zhang, Mitchell J Weiss, David Pellman. Nat Genet 2021
88